...
首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Functional Regulation of ClC-3 in the Migration of Vascular Smooth Muscle CellsNovelty and Significance
【24h】

Functional Regulation of ClC-3 in the Migration of Vascular Smooth Muscle CellsNovelty and Significance

机译:ClC-3在血管平滑肌细胞迁移中的功能调节作用及其意义

获取原文

摘要

Migration of vascular smooth muscle cells (VSMCs) into neointima contributes to atherosclerosis and restenosis. This migration requires coordinated plasmalemmal fluxes of water and ions. Here, we show that aortic VSMC migration depends on the regulation of transmembrane Cl? flux by ClC-3, a Cl? channel/transporter. The contribution of ClC-3 to plasmalemmal Cl? current was studied in VSMCs by electrophysiological recordings. Cl? current was negligible in cells perfused with 0 [Ca2+]. Raising intracellular [Ca2+] to 0.5 μM activated a Cl? current (ICl.Ca), approximately half of which was eliminated on inhibition by KN-93 of calmodulin-dependent protein kinase II. ICl.Ca was also halved by inositol-3,4,5,6-tetrakisphosphate, a cellular signal with the biological function of specifically preventing calmodulin-dependent protein kinase II from activating ICl.Ca. Gene disruption of ClC-3 reduced ICl.Ca by 50%. Moreover, ICl.Ca in the ClC-3 null VSMCs was not affected by either KN-93 or inositol-3,4,5,6-tetrakisphosphate. We conclude that ICl.Ca is composed of 2 components, one is ClC-3 independent whereas the other is ClC-3 dependent, activated by calmodulin-dependent protein kinase II and inhibited by inositol-3,4,5,6-tetrakisphosphate. We also assayed VSMC migration in transwell assays. Migration was halved in ClC-3 null cells versus wild-type cells. In addition, inhibition of ClC-3 by niflumic acid, KN-93, or inositol-3,4,5,6-tetrakisphosphate each reduced cell migration in wild-type cells but not in ClC-3 null cells. These cell-signaling roles of ClC-3 in VSMC migration suggest new therapeutic approaches to vascular remodeling diseases.
机译:血管平滑肌细胞(VSMC)向新内膜的迁移有助于动脉粥样硬化和再狭窄。这种迁移需要水和离子的等离子通量协调一致。在这里,我们表明主动脉VSMC的迁移取决于跨膜Cl? ClC-3的通量,Cl?渠道/运输商。 ClC-3对血浆中Cl?的贡献通过电生理记录研究了VSMC中的电流。 Cl吗在用0 [Ca2 +]灌注的细胞中,电流可以忽略不计。将细胞内[Ca2 +]升高至0.5μM可激活Cl?电流(IC1.Ca),其中约一半在被KN-93抑制钙调蛋白依赖性蛋白激酶II时被消除。 ICl.Ca也被肌醇3,4,5,6-四磷酸磷酸酯减半,这是一种细胞信号,具有特异性阻止钙调蛋白依赖性蛋白激酶II激活ICl.Ca的生物学功能。 ClC-3的基因破坏使ICl.Ca减少了50%。此外,ClC-3空VSMC中的ICl.Ca不受KN-93或肌醇-3,4,5,6-四磷酸酯的影响。我们得出的结论是,ICl.Ca由2个成分组成,一个成分是ClC-3独立的,而另一个成分是ClC-3依赖性的,被钙调蛋白依赖性蛋白激酶II激活,并被肌醇3,4,5,6-四磷酸抑制。我们还在transwell分析中分析了VSMC迁移。与野生型细胞相比,ClC-3空细胞的迁移减少了一半。另外,尼氟酸,KN-93或肌醇-3,4,5,6-四磷酸对ClC-3的抑制作用均减少了野生型细胞中的细胞迁移,但未减少ClC-3无效细胞中的细胞迁移。 ClC-3在VSMC迁移中的这些细胞信号作用表明了血管重塑疾病的新治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号